JPY5,203.00
0.84%
Tokyo, Sep 16, 07:50 am CET
ISIN
JP3160400002
Symbol
4523
Index

Eisai Stock price

JPY5,183.00
+522.00 11.20% 1M
+876.00 20.34% 6M
+854.00 19.73% YTD
-646.00 11.08% 1Y
-825.00 13.73% 3Y
-4,252.00 45.07% 5Y
-2,773.00 34.85% 10Y
+683.00 15.18% 20Y
Tokyo, Closing price Tue, Sep 16 2025
-64.00 1.22%
ISIN
JP3160400002
Symbol
4523
Index
Industry

Key metrics

Basic
Market capitalization
JPY1.5t
Enterprise Value
JPY1.4t
Net debt
positive
Cash
JPY286.1b
Shares outstanding
282.1m
Valuation (TTM | estimate)
P/E
29.4 | 33.0
P/S
1.8 | 1.8
EV/Sales
1.8 | 1.8
EV/FCF
100.1
P/B
1.8
Dividends
DPS
JPY160.00
Yield 1Y | 5Y
3.1% | 2.4%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
97.7% | 95.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
JPY803.0b | JPY809.1b
EBITDA
JPY101.3b | JPY102.5b
EBIT
JPY61.7b | JPY71.2b
Net Income
JPY50.3b | JPY44.9b
Free Cash Flow
JPY14.3b
Growth (TTM | estimate)
Revenue
9.4% | 2.5%
EBITDA
25.8% | 40.0%
EBIT
51.3% | 43.8%
Net Income
54.1% | -3.3%
Free Cash Flow
2.9%
Margin (TTM | estimate)
Gross
78.6%
EBITDA
12.6% | 12.7%
EBIT
7.7%
Net
6.3% | 5.6%
Free Cash Flow
1.8%
Financial Health
Equity Ratio
60.7%
Return on Equity
5.5%
ROCE
6.2%
ROIC
5.6%
Debt/Equity
0.3
More
EPS
JPY178.5
FCF per Share
JPY50.7
Short interest
-
Employees
11k
Rev per Employee
JPY71.3m
Show more

Is Eisai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,016 stocks worldwide.

Eisai Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Eisai forecast:

8x Buy
44%
9x Hold
50%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Eisai forecast:

Buy
44%
Hold
50%
Sell
6%

Financial data from Eisai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
803,022 803,022
9% 9%
100%
- Direct Costs 171,650 171,650
14% 14%
21%
631,372 631,372
8% 8%
79%
- Selling and Administrative Expenses 408,603 408,603
5% 5%
51%
- Research and Development Expense 168,689 168,689
0% 0%
21%
101,256 101,256
26% 26%
13%
- Depreciation and Amortization 39,541 39,541
0% 0%
5%
EBIT (Operating Income) EBIT 61,715 61,715
51% 51%
8%
Net Profit 50,325 50,325
54% 54%
6%

In millions JPY.

Don't miss a Thing! We will send you all news about Eisai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Haruo Naito
Employees 11,067
Founded 1936
Website www.eisai.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today